Proenkephalin for Prediction of Contrast-Associated Kidney Events

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

December 31, 2021

Conditions
Contrast-induced NephropathyAcute Kidney InjuryCoronary Artery Disease
Interventions
DIAGNOSTIC_TEST

blood-draw for biomarker analyses

Blood will be drawn at three time-points: immediately before catherization, 12-24 hours after catheterization and 4-8 weeks after discharge. Creatinine will be measured for endpoint definition, while the markers urea, CRP (C-reactive protein), NGAL (neutrophil gelatinase-associated lipocalin), KIM-1 (kidney injury marker-1), cystatin C, suPAR (soluble urokinase-type plasminogen activator receptor), and penKid will be measured as biomarkers of interest.

Trial Locations (1)

20246

University Heart Center Hamburg, Hamburg

All Listed Sponsors
lead

Dr. med. Mahir Karakas

OTHER

NCT03989505 - Proenkephalin for Prediction of Contrast-Associated Kidney Events | Biotech Hunter | Biotech Hunter